Skip to Primary Navigation

Skip to main content

Former pharma CEO agrees $30k settlement with SEC over fraud allegations

A photo of the front of the headquarters of the U.S. Securities and Exchange Commission.
Photo by Anna Moneymaker/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Anthony J Cataldo, who was accused of diverting millions in company funds, agreed to settle fraud allegations for a fraction of the amount regulators say he stole.

A former pharmaceutical executive has agreed to settle federal charges accusing him of siphoning more $3.2m from the company he once led, according to a complaint filed by the SEC.

Regulators allege that between November 2020 and October 2021, Anthony J Cataldo repeatedly transferred corporate funds into his personal bank

According to

, , , , , ,